ICAM1 and systemic sclerosis: Increased expression of ICAM-1 in skin and circulating in the serum of SSc patients has been reported (Ihn et al., 1997; Majewski et al., 1991), which could provide the initial stimulus to break B cell tolerance to this widely expressed adhesion molecule.